Pacific Shuanglin Bio pharmacy Co Ltd (000403)

Currency in CNY
18.89
+0.49(+2.66%)
Closed·
000403 Scorecard
Full Analysis
Has raised its dividend for 4 consecutive years
000403 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
18.2019.13
52 wk Range
16.5527.25
Key Statistics
Bid/Ask
18.88 / 18.88
Prev. Close
18.4
Open
18.3
Day's Range
18.2-19.13
52 wk Range
16.55-27.25
Volume
25.07M
Average Volume (3m)
15.79M
1-Year Change
-27.7%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
000403 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
20.84
Upside
+10.32%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Pacific Shuanglin Bio pharmacy Co Ltd Company Profile

Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in research, development, production, and sales of blood products in China. Its lead products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin (PH4), hepatitis B human immunoglobulin, tetanus human immunoglobulin, rabies patient immunoglobulin, and human coagulation factor. addition, it engages in the investment, consultation, and technology promotion of pharmaceutical and biotechnology development projects; and electronic product information consultation. The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021. Pacific Shuanglin Bio-pharmacy Co., Ltd. was founded in 1993 and is based in Taiyuan, China.

Employees
2635
Market
China

Compare 000403 to Peers and Sector

Metrics to compare
000403
Peers
Sector
Relationship
P/E Ratio
24.5x37.3x−0.5x
PEG Ratio
7.340.580.00
Price/Book
2.2x2.7x2.6x
Price / LTM Sales
6.7x6.9x3.3x
Upside (Analyst Target)
9.7%3.6%43.4%
Fair Value Upside
Unlock8.8%7.1%Unlock

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 20.84
(+10.32% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.74%
Dividend Yield
3.28%
Industry Median 1.51%
Annualised payout
0.62
Paid unevenly
5-Years Growth
+49.27%
Growth Streak

Earnings

Latest Release
Apr 23, 2025
EPS / Forecast
0.09 / 0.28
Revenue / Forecast
374.65M / --
EPS Revisions
Last 90 days

000403 Income Statement

FAQ

What Stock Exchange Does Pacific Shuanglin Bio pharmacy Trade On?

Pacific Shuanglin Bio pharmacy is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Pacific Shuanglin Bio pharmacy?

The stock symbol for Pacific Shuanglin Bio pharmacy is "000403."

What Is the Pacific Shuanglin Bio pharmacy Market Cap?

As of today, Pacific Shuanglin Bio pharmacy market cap is 17.95B.

What Is Pacific Shuanglin Bio pharmacy's Earnings Per Share (TTM)?

The Pacific Shuanglin Bio pharmacy EPS (TTM) is 0.74.

When Is the Next Pacific Shuanglin Bio pharmacy Earnings Date?

Pacific Shuanglin Bio pharmacy will release its next earnings report on 02 Nov 2025.

From a Technical Analysis Perspective, Is 000403 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Pacific Shuanglin Bio pharmacy Stock Split?

Pacific Shuanglin Bio pharmacy has split 5 times.

How Many Employees Does Pacific Shuanglin Bio pharmacy Have?

Pacific Shuanglin Bio pharmacy has 2635 employees.

What is the current trading status of Pacific Shuanglin Bio pharmacy (000403)?

As of 08 Aug 2025, Pacific Shuanglin Bio pharmacy (000403) is trading at a price of 18.89, with a previous close of 18.40. The stock has fluctuated within a day range of 18.20 to 19.13, while its 52-week range spans from 16.55 to 27.25.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.